相关实验视频
Updated: May 5, 2026

05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
37.8K
在老鼠海马体中改善抑郁症引起的行为,组织和分子变化
Mahsa Otarkhani1, Homeira Hatami1, Yousef Panahi2
1Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|August 22, 2025
概括
通过减少氧化应激和改善海马组织健康,囊化西丁有效治疗老鼠的抑郁症. 这种新型的输送系统增强了hesperidin
科学领域:
- 神经科学
- 药理学
- 生物技术
背景情况:
- 像抑郁症这样的神经疾病需要有效的药物输送系统.
- 体载体可以向大脑输送治疗剂.
- 赫斯佩里丁是一种具有潜在抗抑郁功能的黄类化合物.
研究的目的:
- 评估体封装素 (nHes) 对大鼠保留素诱导的抑郁症的治疗效果.
- 研究nHes对氧化应激标记,TRPM2和TRPC1基因表达以及海马组织学的影响.
主要方法:
- 使用Reserpine诱导大鼠的抑郁症,然后用hesperidin (Hes) 或体封装hesperidin (nHes) 进行治疗.
- 行为测试 (强迫游泳测试,糖偏好测试) 评估了类似抑郁症的行为.
- 对海马组织进行了氧化应激标记 (GPX,MDA),基因表达 (TRPM2,TRPC1) 和组织学变化的分析.
主要成果:
- 在患有抑郁症的老鼠中,nHes治疗显著降低了不运动性和增加了糖分偏好.
- 与抑郁症组相比,nHes降低了TRPM2基因表达,而Hes则降低了TRPC1基因表达.
- 组织学研究显示,nHes治疗的老鼠的海马细胞的亡减少,活细胞增加.
结论:
- 在老鼠模型中,体封装的素有效地改善了抑郁症表型.
- 治疗效益归因于降低海马氧化应激和组织病理改善.
- 脂质体载体增强了西治疗抑郁症的有效性和生物可用性.
更多相关视频
相关概念视频
Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Heart Failure V: Medical Management
626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753

